These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 27649548)
41. Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens. Bag S; Tawari NR; Degani MS; Queener SF Bioorg Med Chem; 2010 May; 18(9):3187-97. PubMed ID: 20363634 [TBL] [Abstract][Full Text] [Related]
42. Nonlinear quantitative structure-activity relationship for the inhibition of dihydrofolate reductase by pyrimidines. Hirst JD J Med Chem; 1996 Aug; 39(18):3526-32. PubMed ID: 8784450 [TBL] [Abstract][Full Text] [Related]
43. Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania. Zuccotto F; Martin AC; Laskowski RA; Thornton JM; Gilbert IH J Comput Aided Mol Des; 1998 May; 12(3):241-57. PubMed ID: 9749368 [TBL] [Abstract][Full Text] [Related]
44. Preparation, biological evaluation and molecular docking study of imidazolyl dihydropyrimidines as potential Mycobacterium tuberculosis dihydrofolate reductase inhibitors. Desai NC; Trivedi AR; Khedkar VM Bioorg Med Chem Lett; 2016 Aug; 26(16):4030-5. PubMed ID: 27397497 [TBL] [Abstract][Full Text] [Related]
45. Two- and Three-dimensional Quantitative Structure-activity Relationship Models Based on Conformer Structures. Nitta F; Kaneko H Mol Inform; 2021 Mar; 40(3):e2000123. PubMed ID: 32893463 [TBL] [Abstract][Full Text] [Related]
46. Towards a MIP-based alignment and docking in computer-aided drug design. Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890 [TBL] [Abstract][Full Text] [Related]
47. Analysis of Coxiela burnetti dihydrofolate reductase via in silico docking with inhibitors and molecular dynamics simulation. de Souza FR; Guimarães AP; Cuya T; de Freitas MP; Gonçalves ADS; Forgione P; Costa França TC J Biomol Struct Dyn; 2017 Oct; 35(13):2975-2986. PubMed ID: 27726597 [TBL] [Abstract][Full Text] [Related]
48. The Structural Basis for Nonsteroidal Anti-Inflammatory Drug Inhibition of Human Dihydrofolate Reductase. Duff MR; Gabel SA; Pedersen LC; DeRose EF; Krahn JM; Howell EE; London RE J Med Chem; 2020 Aug; 63(15):8314-8324. PubMed ID: 32658475 [TBL] [Abstract][Full Text] [Related]
49. The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability. Dams T; Auerbach G; Bader G; Jacob U; Ploom T; Huber R; Jaenicke R J Mol Biol; 2000 Mar; 297(3):659-72. PubMed ID: 10731419 [TBL] [Abstract][Full Text] [Related]
50. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints. Kumar A; Siddiqi MI J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358 [TBL] [Abstract][Full Text] [Related]
51. Structural similarity based kriging for quantitative structure activity and property relationship modeling. Teixeira AL; Falcao AO J Chem Inf Model; 2014 Jul; 54(7):1833-49. PubMed ID: 24897621 [TBL] [Abstract][Full Text] [Related]
52. Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase. Bastien D; Ebert MC; Forge D; Toulouse J; Kadnikova N; Perron F; Mayence A; Huang TL; Vanden Eynde JJ; Pelletier JN J Med Chem; 2012 Apr; 55(7):3182-92. PubMed ID: 22424148 [TBL] [Abstract][Full Text] [Related]
53. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase. Fogel GB; Cheung M; Pittman E; Hecht D J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315 [TBL] [Abstract][Full Text] [Related]
54. Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis. Wyatt EE; Galloway WR; Thomas GL; Welch M; Loiseleur O; Plowright AT; Spring DR Chem Commun (Camb); 2008 Oct; (40):4962-4. PubMed ID: 18931753 [TBL] [Abstract][Full Text] [Related]